Hide Board Information

Show Board Information

FingerMotion Inc FNGR

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/17/2025 4:49:09 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 3

FingerMotion Inc (OTCMRKTS: FNGR) Stock Message Board

1. FNGR Company Profile

    

2. FNGR Time & Sales

    

3. FNGR Recent News

    

4. FNGR Filings

    

5. FNGR Financials

    

6. FNGR Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

11	NetworkNewsBreaks FingerMotion Inc. (FNGR) to	NetworkNewsWire	05/13/2021 4:00:15 PM
10	Potential A-Share Listings by Chinas Telecom	NetworkNewsWire	05/10/2021 4:30:07 PM
9	Ready for thos to head higher. Last few days	b4ucry	05/05/2021 9:07:21 AM
8	FingerMotion Inc. (FNGR) Leveraging Raw Mobile	NetworkNewsWire	05/04/2021 4:50:05 PM
7	NetworkNewsBreaks FingerMotion Inc. (FNGR)	NetworkNewsWire	05/04/2021 4:28:17 PM
6	NetworkNewsBreaks FingerMotion Inc. (FNGR)	NetworkNewsWire	04/30/2021 7:49:22 PM
5	Chinas Huge Landscape for Telecommunications	NetworkNewsWire	04/26/2021 3:05:03 PM
4	NetworkNewsBreaks FingerMotion Inc. (FNGR)	NetworkNewsWire	04/22/2021 4:56:33 PM
3	FingerMotion Inc. (FNGR) on Track to Monetize its	NetworkNewsWire	04/16/2021 4:59:25 PM
2	FingerMotion Inc. (FNGR) Reports Ongoing Revenue	NetworkNewsWire	04/13/2021 4:00:18 PM
1	NetworkNewsBreaks Why FingerMotion Inc.	NetworkNewsWire	04/13/2021 3:40:39 PM

Newer

Recent Articles

• Autoliv's Strategic Move: Retiring Shares for Growth
• Autoliv Takes Significant Steps by Retiring Shares Efficiently
• VARON Oxygen Solutions: Empowering Freedom Through Innovation
• Docusign Expands Leadership with Stéphane Barberet in EMEA
• Skanska's Major Investment in Sustainable Housing Development
• Understanding the Monthly Factsheet for Tetragon Financial
• Hansa Biopharma Offers Promising Insights on Imlifidase in Transplants
• Positive Five-Year Data on Imlifidase in Kidney Transplants
• Amaroq Minerals Closes Major Fundraising Effort
• Elis Enhances Shareholder Value Through Strategic Buybacks
• IMCD Expands Horizons with Acquisition of Apus Química
• KuCoin Thailand Partners with Finansia Syrus to Enhance Assets
• Understanding Aktsiaselts Infortar's Dividends and Operations
• AB Science Updates Loan Restructuring for Strategic Growth
• Haffner Energy Achieves Key Milestones in 2024-2025 Financial Year
• Skanska Commits CZK 1.6 Billion to Innovative Housing Project
• SWI Group Strengthens European Strategy with New Data Centre
• Tetragon Financial Group's Monthly Overview and Insights
• SWI Group's Innovative Data Centre Expansion in Europe
• MIMARU Introduces Enhanced Rooms to Enchant Pokemon Fans
• Klotho Neurosciences Advances Gene Therapy for ALS Patients
• KuCoin Thailand Partners with Finansia Syrus to Innovate Digital Assets
• Aker Solutions and Cognizant Team Up for IT Modernization
• IMCD Enhances Advanced Materials Solutions with Apus Química
• Infortar Announces Upcoming Dividend Payments for Shareholders
• Trifork Group's Commitment to Shareholder Value Through Buyback
• Revolutionary IoT Chip by CT Group Poised to Dominate Market
• Nextensa and Promobe Team Up for Eosys Development
• Sermatec and Foxconn Drive Innovation in Energy Storage Solutions
• The Bouzy Group Unveils New Coastal Lifestyle Investment Option
• Vallourec Enhances Collaboration with ADNOC Through Major Order
• Nextensa Advancing Footprint with Eosys Construction Project
• Endeavour Mining's Recent Share Buy-Back Program Highlights
• Celebrating 20 Years of Reddit: A Distinctive Social Media Journey
• Nicox Achieves Major Milestone in NCX 470 Clinical Trial
• Vallourec's Major Supply Order from ADNOC Signals Growth
• Sanofi Announces Release of Q2 2025 Aide Mémoire for Investors
• Fosun International's Accolades Highlight Corporate Excellence
• Exciting Progress: Nicox's NCX 470 Trial Nears Major Milestone
• Sanofi Unveils Release of Q2 2025 Financial Insights
• Totalkredit A/S Unveils Latest Prepayment Insights and Data
• Prepayment Trends and Insights from Nykredit Realkredit A/S
• Exciting Launch: White Castle's New Crispy Chicken Slider
• Idorsia's Innovative Vaccine Platform: A New Era in Medicine
• Addex Therapeutics Invests CHF 2 Million in Stalicla for CNS Innovation
• ARGX-119 Clinical Advancement: A New Era for CMS Treatment
• Roche Announces Leadership Changes in Executive Committee
• Riliprubart Receives Orphan Drug Designation in Japan for CIDP
• SEALSQ Corp Enhances Quantum Resilience through Investment in WECAN
• Riliprubart's Orphan Drug Designation: A Path to Innovation